Literature DB >> 6019133

Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

H J Müller-Eberhard, M J Polley, M A Calcott.   

Abstract

A functional unit of the human complement system has been delineated. It is composed of two subunits which are derived from the second (C'2) and from the fourth (C'4) component of complement. Purified C'2 and C'4 were found to interact in free solution and to form a reversible protein-protein complex. When acted upon by C'1 esterase in the presence of Mg ions, the reversible complex acquires stability and the ability to act enzymatically on the third component of complement. The trivial name C'3 convertase has been selected to denote the enzyme. Molecular weight determinations suggest that the entire C'4 molecule, but probably only a fragment of the C'2 molecule, are incorporated into C'3 convertase. Prior treatment of C'2 with iodine led to enhanced stability and activity of the enzyme. It was shown that the cell-bound form of C'3 convertase is cytolytically active and that the free enzyme is able to induce lysis from the fluid phase of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. Evidence was presented that action of C'3 convertase on C'3 results in fragmentation of the molecule.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6019133      PMCID: PMC2138355          DOI: 10.1084/jem.125.2.359

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  Complement and Hemolysis.

Authors:  H J Rapp; T Borsos
Journal:  Science       Date:  1963-08-23       Impact factor: 47.728

3.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

4.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

6.  Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.

Authors:  A P Dalmasso; H J Müller-Eberhard
Journal:  J Immunol       Date:  1966-11       Impact factor: 5.422

7.  THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.

Authors:  G B NAFF; J PENSKY; I H LEPOW
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

8.  C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; I H LEPOW
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

9.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  78 in total

1.  Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.

Authors:  H Okada; N Okada
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.

Authors:  S Ruddy; K F Austen; E J Goetzl
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

3.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

Review 4.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

5.  Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.

Authors:  C W Cutler; J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  Purificaiton and characterization of mouse serum protein with specific binding affinity for C4 (Ss protein).

Authors:  A Ferreira; M Takahashi; V Nussenzweig
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

Review 7.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

8.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.